Lonza Biologics Inc

Acerta Pharma, an affiliate of AstraZeneca, is at the forefront of advancing care in haematology by developing innovative investigational agents aimed at directly targeting cancer cells and harnessing the immune system to combat cancer. The company focuses on addressing blood cancers with significant unmet needs by enriching its pipeline with first-in-class and best-in-class medicines. In collaboration with AstraZeneca, Acerta Pharma employs cutting-edge drug discovery techniques to create transformational therapies for patients with hematological malignancies. With a state-of-the-art research and development center in the Netherlands, the company fosters partnerships with academic and commercial entities to enhance its oncology portfolio. Generated from the website

CytomX Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, dedicated to innovating cancer treatment through its unique Probody therapeutics. With a focus on developing potent and less toxic anti-cancer medications, CytomX aims to transform the lives of patients by providing a new generation of life-changing treatment options. The company emphasizes a mission-driven culture that values diversity, equity, and inclusion, recognizing that diverse perspectives enhance creativity and innovation. CytomX is committed to fostering an environment where individuals feel respected and connected, working collaboratively to achieve both corporate and individual objectives in the fight against cancer. Generated from the website

Ultragenyx Pharmaceutical Inc, based in Novato, is at the forefront of rare disease medicine, dedicated to advancing the rare disease community. With a commitment to progress and innovation, Ultragenyx is shaping the future of healthcare for those with rare diseases. Driven by a mission to propel the rare disease field forward, Ultragenyx Pharmaceutical Inc is a leader in developing treatments and therapies for those in need. Their focus on rare diseases underscores their dedication to improving the lives of patients and caregivers worldwide. Generated from their website's infomation